FAM
PALI icon

Fred Alger Management’s Palisade Bio PALI Stock Holding History

Fred Alger Management’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1
Closed -$3.71M – 703
2014
Q4 		$3.71M Hold
1
– – 0.02% 353
2014
Q3 		$4.61M Hold
1
– – 0.02% 349
2014
Q2 		$6.03M Sell
1
-1
-50% -$4.7M 0.03% 343
2014
Q1 		$7.48M Buy
+2
New +$8.28M 0.04% 324

Other funds holding PALI

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fred Alger Management's PALI Position: Q1 2015 in Review

Fred Alger Management sold out of Palisade Bio (PALI) in Q1 2015, closing a stake of 1 share — an estimated $3.71M sold.

Fred Alger Management first reported a position in PALI in Q1 2014 and held it in 4 quarters. The position peaked at $7.48M in Q1 2014. 7 funds tracked by Wall St. Rank hold PALI as of Q1 2015.

  • Fred Alger Management reported no remaining Palisade Bio position as of Q1 2015 after selling out during the quarter.
  • Fred Alger Management sold 1 Palisade Bio share in Q1 2015, an estimated $3.71M.
  • Fred Alger Management first reported a position in Palisade Bio in Q1 2014 and held it in 4 quarters.
  • Fred Alger Management's Palisade Bio position peaked at $7.48M in Q1 2014.
  • 7 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2015.

Based on Fred Alger Management's 13F filing for Q1 2015, filed 15 May 2015.